Research & Disclosures

“Pain Rounds” is a supplemental educational resource to be used in a fashion similar to a textbook. It is not intended to replace clinical training or to provide any kind of medical licensing or certification. 

Hypothesis

After completion of the entire video series, pain fellows will feel more equipped to pursue neuromodulation procedures regardless of institutional variability.

Research Methods

  • Needs-based assessment
  • Pre-test/post-tests which assesses:
    1. Comfort level with neuromodulation
    2. Likelihood of performing cases post-fellowship based on current curriculum
    3. Knowledge level

DisclosureS

Project is funded as an unrestricted educational research grant at Johns Hopkins School of Medicine. Nevro Corporation provided the funding but has no control of content. We promise unbiased videos that in no form promote any particular company.

Disclosures for "Pain Rounds" Host & Guests


Kerry Bradley, MS    

Senior Director, Research

Nevro Corporation

Stock Ownership: Abbott, Boston Scientific, Nevro Corporation


James Chao, MD, FACS

Medical Director

OasisMD Lifestyle Healthcare

Consultant: Boston Scientific


Tim Deer, MD, DABPM

President & CEO

The Spine & Nerve Centers of the Virginias

Consultant: Abbott, Vertos, Axonics, Flowonix, Saluda Medical, Vertos, SpineThera, Nalu, Cornerloc, SPR Therapeutics, Vertiflex

Advisory Board: Abbott, Flowonix, Nalu, SPR Therapeutics, Vertiflex

Equity Options: Bioness, Vertiflex, Axonics, Vertos, SpineThera, Saluda Medicals, Nalu, Cornerloc

Research Consultant: Abbott, Mainstay Medical, Saluda, SPR Therapeutics, Vertiflex

Patent Pending for the DRG Paddle Lead: Abbott


Shravani Durbhakula, MD

Assistant Professor & Pain Medicine Fellowship Director

Johns Hopkins School of Medicine

Advisory Board: BioTras

Research Funding: Nevro


Maged Guirguis, MD

System Chair of Interventional Pain Medicine

Ochsner Health System

Consultant: Nevro, Boston Scientific, Avanos

Research: Nevro, Boston Scientific, Avanos, Abbott, Neuros, SPR Therapeutic


Robert Levy, MD, PhD  

President, International Neuromodulation Society

Editor-in-Chief, Neuromodulation: Technology at the Neural Interface

Consultant: Abbott, Saluda, Nuvectra, Nalu, Mainstay Medical

Stock Options >5%: Nalu, Bioness, Vertos, Nevro

Stock Ownership: Nevro


Sean Li, MD

Regional Medical Director

Premier Pain Centers

Consultant: Abbott, Avanos, Nalu, Nevro, Saluda, SI-Bone, Vertiflex, Vertos

Grant/Research Support: Avanos, Biotronik, Nevro, Vertiflex, Saluda, SPR

Advisory Board: Abbott, Biotras, Nalu, Nevro, Saluda

Stock Shareholder/Equity: Axonics, BioTras, National Spine and Pain Centers, Nevro, Suture Concepts


Neel Mehta, MD    

Medical Director, Pain Medicine

Weill Cornell Medical College

Consultant: Nevro

Advisor: Nuvectra

Research Funds in the Past 12 Months: Boston Scientific, Nevro, Abbott, Medtronic


Susan Moeschler, MD  

Associate Professor & Pain Medicine Fellowship Director

Mayo Clinic


Yeshvant Navalgund, MD

Assistant Professor, West Virginia University

Co-Founder, DNA Advanced Pain Treatment Center

Consultant: Nevro, Medtronic, Abbott, Nuvectra


Daniel Pak, MD    

Anesthesiology & Pain Medicine

Massachusetts General Hospital, Harvard Medical School


Erika Petersen, MD

Associate Professor & Director of Functional and Restorative Neurosurgery

University of Arkansas for Medical Sciences

Research Support or PI for Funded Industry Research: Nevro, Medtronic, Neuros Medical, ReNeuron

Faculty/Consulting: Abbott DBS, Medtronic DBS, Nevro

Advisory Board (Stock Options): SynerFuse


Peter Staats, MD, MBA, FIPP, ABIPP, DABPM

Chief Medical Officer

National Spine & Pain Centers

Consulting & Research Grants: Medtronic, Boston Scientific, Nevro, Abbott, Saluda

Founder: electroCore

Shareholder: electroCore, SPR Therapeutics, Nalu